Mary is the Global Content Strategy and US Regional Lead for Pfizer Medical Information [MI]. Mary earned both a Bachelors and Doctorate degree in Pharmacy. Mary has greater than 20 years pharmaceutical industry experience specific to medical information. Outside of Pfizer, Mary is active in advancing the medical information profession through her leadership/collaboration roles in the Drug Information Association and phactMI [Pharma Collaboration for Transparent Medical Information]. Mary is currently serving on the phactMI board of directors for the term 2019-2020.

Stuart Sowder, Vice President at Pfizer is currently responsible for compliance oversight for Asia, Pacific, African, and the Middle East. He is based in Tokyo. Previously, he led Pfizer’s External Medical Communications (EMC). Stuart received a B.S. degree in Pharmacy, his Doctorate of Pharmacy, and a JD at New York Law School. He earned a MBA from Duke University’s Fuqua School of Business. Stuart joined Pfizer in 1997 after a career in hospital pharmacy at the Veteran’s Administration in Manhattan. Since joining Pfizer, he has held positions of increasing responsibility starting in the field force, moving on to Pfizer Outcomes Research, the Regional Medical Research Specialists, External Medical Communications, and now Compliance.

Jeff Francer serves as Vice President, Head of International Regulatory Affairs and Global Regulatory Policy for Eli Lilly and Company. In this role, Jeff leads Lilly’s interactions with regulators and submissions in the Asia-Pacific, Europe, Middle East, and Africa regions. Jeff also leads Lilly’s global regulatory policy team. Jeff has led and advised biopharmaceutical companies and policy makers for over 25 years to craft regulatory systems that best meet the needs of patients and improve public health. Prior to joining Lilly in 2023, Jeff has served as Associate Chief Counsel of the FDA, Vice President and Senior Counsel at PhRMA, and Senior Vice President and General Counsel of the Association for Accessible Medicines.

Kristin Graham Koehler is a partner in the Washington, DC Office of Sidley Austin LLP and has significant experience in developing corporate compliance and audit programs in the life sciences industry. And, she has negotiated numerous Corporate Integrity Agreements with the HHS OIG.